Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Comparison of five different reagents for anticardiolipin antibodies determination (CROSBI ID 713185)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Đerek, Lovorka ; Drvar, Vedrana ; Stančin, Nevenka ; Njegovan, Milena ; Vukasović, Ines ; Tešija Kuna, Andrea Comparison of five different reagents for anticardiolipin antibodies determination // Autoimmunity 2021, Athens: 12th International Congress on Autoimmunity. Kenes Group, 2021

Podaci o odgovornosti

Đerek, Lovorka ; Drvar, Vedrana ; Stančin, Nevenka ; Njegovan, Milena ; Vukasović, Ines ; Tešija Kuna, Andrea

engleski

Comparison of five different reagents for anticardiolipin antibodies determination

Background and aims AnticardiolipinsIgG (aCL-IgG) and IgM (aCL-IgM) antibodies are used asone of the criteria forantiphospholipid syndrome (APS). Our aim was to compare the results of five different methods for anticardiolipinantibodiesto obtain an insight into method comparability. Methods The study included 38 patients (35 women and 3 men) with history or suspicion of thrombotic event. aCL-IgG and aCL-IgM were measured using 5 different reagents: Anti-CardiolipinELISA on Analyzer I-2P (all EUROIMMUN AG, Lubeck, Germany), CardiolipinIgGandIgMchemiluminiscentimmunoassay (CLIA) on IDS iSYS (all Immunodiagnostic Systems Limited, Boldon, United Kingdom), QUANTA Flash® aCLCLIA on BIO-FLASH® (all Inova Diagnostics Inc, San Diego, USA), EliACardiolipinfluoroenzymeimmunoassay on Phadia 100 (all ThermoFisherDiagnosticsGmbHFreiburg, Germany) and Anti-CardiolipinIgG/IgM ELISA (Orgentec, Mainz, Germany). Results were categorized as positive or negative and interclass correlation coefficient was calculated (MedCalc version 14.8.1) Results Interclass correlation coefficient showed very good degree of consistency inaverage (interclass correlation:aCL-IgG 0, 7789(95%CI:0, 6442-0, 8732) and aCL-IgM 0, 8594(95%CI:0, 2659-0, 5793)) but poor or moderate reliability on single ratings (interclass correlation:aCL- IgG0, 4133(95%CI:0, 2659-0, 5793) andaCL-IgM 0, 5501(95%CI:0, 4063-0, 6952)). Conclusions Our results showed a poor comparability betweenaCLmethods which indicates a lack of standardization. Considering our results we give rise to the fact thatit is possibleto obtain different information from one aCL result for the same patient. The importance of simultaneous measurement of all antibodies included in the APS criteria should be emphasized in order to obtain clinically significant information.

anticardiolipin antibodies ; antiphospholipid syndrome ; comparison of methods

Kongres je održan u virtualnom okruženju. Knjiga sažetaka objavljena na CD mediju.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

667

2021.

objavljeno

Podaci o matičnoj publikaciji

Autoimmunity 2021, Athens: 12th International Congress on Autoimmunity

Kenes Group

Podaci o skupu

12th International Congress on Autoimmunity

poster

28.05.2021-01.06.2021

Atena, Grčka

Povezanost rada

Farmacija, Kliničke medicinske znanosti

Poveznice